Ga naar de inhoud
Home » Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump

Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump

The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales…  Read More